Download PDFPDF
Effect of oral glucocorticoid treatment on serum inflammatory markers in acute asthma
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Re: Oral steroids and inflammatory markers in asthma

    Dear Editor,

    We thank Dr Grigg for his interest in our work.[1] We agree that the asthma attacks may have resolved spontaneously in some cases, which was precisely why we stated that the markers fell in association with steroid therapy, and nowhere implied causality. Nevertheless, the statistical analysis suggests that the chances this occurred at random are extremely low.

    We agree that corticosteroid...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Oral steroids and inflammatory markers in asthma
    Dear Editor:

    Although the paper of El-Radhi et al[1] presents interesting data about decreases in inflammatory markers during the resolution of acute asthma, some of their conclusions are not valid. First, acute asthma has a tendency to resolve without corticosteroid therapy.[2] Since all of the children with acute asthma (quite rightly) received steroids, the observed effect may equally reflect processes associated wit...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Treatment of pediatric asthma is controversial
    Dear Editor:

    The treatment of childhood asthma is controversial: although oral glucocorticoid treatment in children with asthma was associated with clinical improvement.[1] There are concerns about corticosteroids, since stopping drug treatment in children with asthma results in clinical deterioration,[2] or in the return of bronchial hyperresponsiveness within two weeks,[3] with the obvious conclusion that the nat...

    Show More
    Conflict of Interest:
    None declared.